From: Illness perceptions predict distress in patients with chronic kidney disease
Variables | Step 1 (Model 1) | Step 2 (Model 2) | Step 3 (Model 3) | Step 4 (Model 4) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
β | 95% CI for β | Sig | β | 95% CI for β | Sig | β | 95% CI for β | Sig | β | 95% CI for β | Sig | |
Age of Participants |  − 0.15 |  − 0.26 to − 0.03 | 0.01 | 0.01 |  − 0.06 to 0.08 | 0.82 |  − 0.03 |  − 0.10 to 0.05 | 0.45 |  − 0.02 |  − 0.09 to 0.05 | 0.57 |
Sex | 2.7 |  − 0.36 to 5.76 | 0.08 | 1.96 | 0.20 to 3.71 | 0.03 | 2.25 | 0.50 to 4.00 | 0.01 | 1.96 | 0.32 to 3.60 | 0.02 |
eGFR (ml/min/1.73m2) |  − 0.2 |  − 0.28 to − 0.12 | 0.00 |  − 0.02 |  − 0.08 to 0.03 | 0.37 |  − 0.04 |  − 0.09 to 0.01 | 0.13 |  − 0.03 |  − 0.08 to 0.03 | 0.32 |
Albumin (Serum) |  − 0.29 |  − 0.64 to 0.07 | 0.12 |  − 0.03 |  − 0.24 to 0.18 | 0.78 |  − 0.05 |  − 0.26 to 0.15 | 0.60 |  − 0.01 |  − 0.20 to 0.18 | 0.93 |
Haemoglobin A1c |  − 0.41 |  − 0.52 to 1.35 | 0.38 |  − 0.38 |  − 0.16 to 0.92 | 0.16 |  − 0.47 |  − 0.07 to 1.01 | 0.09 |  − 0.52 | 0.02 to 1.02 | 0.04 |
IP Identity | Â | Â | Â | 0.69 | 0.34 to 1.05 | 0.00 | 0.66 | 0.30 to 1.01 | 0.00 | 0.58 | 0.24 to 0.92 | 0.00 |
Timeline Acute − Chronic |  |  |  | 0.18 |  − 0.02 to 0.39 | 0.04 | 0.27 |  − 0.06 to 0.48 | 0.01 | 0.24 |  − 0.04 to 0.45 | 0.02 |
Consequences |  |  |  | 0.07 |  − 0.21 to 0.35 | 0.62 | 0.12 |  − 0.16 to 0.40 | 0.41 | 0.12 |  − 0.14 to 0.38 | 0.35 |
Personal Control |  |  |  |  − 0.51 |  − 0.79 to − 0.23 | 0.00 |  − 0.44 |  − 0.72 to − 0.16 | 0.00 |  − 0.32 |  − 0.58 to − 0.05 | 0.02 |
Treatment Control |  |  |  |  − 0.12 |  − 0.55 to 0.31 | 0.58 |  − 0.12 |  − 0.55 to 0.31 | 0.59 |  − 0.06 |  − 0.51 to 0.39 | 0.79 |
Illness Coherence |  |  |  |  − 0.01 |  − 0.30 to 0.28 | 0.95 |  − 0.04 |  − 0.34 to 0.27 | 0.81 | 0.08 |  − 0.22 to 0.39 | 0.59 |
Timeline Cyclical |  |  |  | 0.23 |  − 0.06 to 0.51 | 0.12 | 0.02 |  − 0.31 to 0.34 | 0.92 | 0.08 |  − 0.25 to 0.40 | 0.65 |
Emotional Reps | Â | Â | Â | 1.01 | 0.77 to 1.25 | 0.00 | 1.00 | 0.77 to 1.24 | 0.00 | 0.84 | 0.61 to 1.07 | 0.00 |
BMQGeneral_Overuse |  |  |  |  |  |  | 0.35 | 0.02 to 0.67 | 0.04 | 0.23 |  − 0.09 to 0.55 | 0.16 |
BMQGeneral_Harm |  |  |  |  |  |  | 0.04 |  − 0.42 to 0.35 | 0.85 | 0.05 |  − 0.36 to 0.46 | 0.81 |
BMQSpecific_Necessity |  |  |  |  |  |  | 0.40 |  − 0.08 to 0.88 | 0.10 | 0.42 |  − 0.02 to 0.86 | 0.06 |
BMQSpecific_Concerns |  |  |  |  |  |  | 0.08 |  − 0.36 to 0.53 | 0.72 | 0.02 |  − 0.41 to 0.45 | 0.92 |
Adaptive Coping |  |  |  |  |  |  |  |  |  |  − 0.09 |  − 0.24 to 0.06 | 0.25 |
Maladaptive Coping | Â | Â | Â | Â | Â | Â | Â | Â | 0.29 | 0.08 to 0.50 | 0.01 | |
MARS5 Score |  |  |  |  |  |  |  |  |  | 0.14 |  − 0.16 to 0.44 | 0.36 |
 |  | R2 = 0.199 |  |  | R2 = 0.771 |  |  | R2 = 0.790 |  |  | R2 = 0.828 |  |
 |  | F(change) = 7.716 |  |  | F(change) = 44.865 |  |  | F(change) = 2.940 |  |  | F(change) = 8.943 |  |
 |  | p < 0.001 |  |  | p < 0.001 |  |  | p < 0.05 |  |  | p < 0.001 |  |